Physicians perceptions of fixed-duration epcoritamab + lenalidomide and rituximab regimens in relapsed/refractory follicular lymphoma: Insights from the epcore NHL-2 trial
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Puja Aggarwal, Robert Bone, Blaise Nwotchouang, Nicholas Moffett, Luke Jennings-Zhang, Solly Chedid, Muhamed Baljevic, Bruce Feinberg
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417016642
Cites:
Cited by:
Related to: